The first gene therapy in the world for Gaucher disease was done here in Calgary. Now we hope to onboard the next study.

A new clinical trial for patients with Phenylketonuria (PKU). At MAGIC Clinic in Calgary. viperclinicaltrials.com

Transforming Prenatal Genetics. Special thanks to Pureform for sponsoring this event. See you there tonight.

The first implementation of Non-Invasive Prental Screening (NIPS) in a community setting in Alberta presented at the CAGC-CCMG meeting in Banff.

Private genomic testing in Alberta for a clinical diagnosis. We presented our first round of data at the CAGC-CCMG meeting in Banff. Out of the Public Exomes the yield was 29.41%. Out of the Private exomes the yield was 54.84%. Private labs are providing results that impact health.

End of day2 Ehler-Danlos Scientific Symposium. What I learned - study showing effects of Irbesartan + Celiprolol in vascular EDS - pregnancy management in vEDS - management practices. And our poster on how to optimize genetic testing in hypermobile patients using exomes / genomes.

Ehlers-Danlos Society 2025 International Scientific Symposium in Toronto. Highlights after the first day:
- a large study of 1000 genomes found no single genetic cause of hypermobility - MTHFR not associated with hypermobility - we presented our poster and study using the FLEx score

viperclinicaltrials.com

Good to see Alberta get the message out.

#alberta

Happy to be part of the Canadian Fabry Association’s meeting in Canmore, Alberta this weekend.

#alberta

Non-Invasive Prenatal Screening in Calgary

Glad to be a part of this new paper. onlinelibrary.wiley.com/journal/1573...

A great event for Rare Disease Day 2025 in Edmonton.

Mortality in Fabry disease. Mortality in rare diseases needs to be a primary target - for every treatment, for every clinic and for every rare disease doctor. Presented at the WORLD Lysosomal meeting in San Diego this past week.

#alberta #canada